Royal London Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $63.3M | Sell |
|
|||||
|
2025
Q1 | $65.3M | Sell |
|
|||||
|
2024
Q4 | $65.3M | Sell |
|
|||||
|
2024
Q3 | $73.5M | Sell |
|
|||||
|
2024
Q2 | $61.7M | Sell |
|
|||||
|
2024
Q1 | $89.5M | Buy |
|
|||||
|
2023
Q4 | $84.6M | Buy |
|
|||||
|
2023
Q3 | $63.2M | Buy |
|
|||||
|
2023
Q2 | $47.7M | Buy |
|
|||||
|
2023
Q1 | $48.1M | Sell |
|
|||||
|
2022
Q4 | $54.1M | Buy |
|
|||||
|
2022
Q3 | $38.4M | Sell |
|
|||||
|
2022
Q2 | $40.4M | Sell |
|
|||||
|
2022
Q1 | $39M | Buy |
|
|||||
|
2021
Q4 | $45.8M | Sell |
|
|||||
|
2021
Q3 | $45.9M | Sell |
|
|||||
|
2021
Q2 | $46.4M | Sell |
|
|||||
|
2021
Q1 | $44.7M | Buy |
|
|||||
|
2020
Q4 | $39.1M | Buy |
|
|||||
|
2020
Q3 | $41.6M | Sell |
|
|||||
|
2020
Q2 | $50.1M | Sell |
|
|||||
|
2020
Q1 | $52.4M | Buy |
|
|||||
|
2019
Q4 | $44.6M | Buy |
|
|||||
|
2019
Q3 | $42.2M | Buy |
|
|||||
|
2019
Q2 | $44.8M | Sell |
|
|||||
|
2019
Q1 | $44.5M | Buy |
|
|||||
|
2018
Q4 | $41.5M | Buy |
|
|||||
|
2018
Q3 | $41.7M | Sell |
|
|||||
|
2018
Q2 | $39.1M | Buy |
|
|||||
|
2016
Q2 | $37.5M | Sell |
|
|||||
|
2016
Q1 | $336K | Buy |
|
|||||
|
2015
Q4 | $52.8M | Sell |
|
|||||
|
2015
Q3 | $51.1M | Buy |
|
|||||
|
2014
Q4 | $716K | Buy |
|
|||||
|
2014
Q3 | $72.7M | Buy |
|
|||||
|
2014
Q2 | $60.9M | Buy |
|
|||||
|
2014
Q1 | $34.2M | Buy |
|
|||||
|
2013
Q4 | $27.6M | Buy |
|
|||||
|
2013
Q3 | $25.4M | Buy |
|
|||||
|
2013
Q2 | $17.8M | Buy |
|